Product Information
ACETAMINOPHEN-COD #4 TABLET is a generic product labeled by Elite Laboratories, Inc., priced at $0.3864 per EA under NDC 64850064305. Its NADAC has been published 25 times since Jan 7, 2026.
Strength
300; 60 mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850064305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212418On Market Since
9/10/2019
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #4 TABLET has been published 25 times since Jan 7, 2026, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3864 per EA |
|---|---|
| All-time high | $0.4473 (Feb 11, 2026) |
| All-time low | $0.3855 (May 20, 2026) |
| 52-week high | $0.4473 |
| 52-week low | $0.3855 |
| Median price | $0.4078 |
| Average price | $0.4116 |
| Largest weekly change | -4.8% (Mar 18, 2026) |
| Weeks tracked | 25 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #4 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #4 TABLET, manufactured by Elite Laboratories, Inc., is $0.3864 per EA (NDC 64850064305), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN-COD #4 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #4 TABLET has declined 11.0%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #4 TABLET?
Since Jan 7, 2026, the NADAC for ACETAMINOPHEN-COD #4 TABLET has ranged from a low of $0.3855 (May 20, 2026) to a high of $0.4473 (Feb 11, 2026), with a median of $0.4078 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #4 TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ACETAMINOPHEN-COD #4 TABLET, but none are currently priced below it.
Who manufactures ACETAMINOPHEN-COD #4 TABLET?
ACETAMINOPHEN-COD #4 TABLET (NDC 64850064305) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification